VIVAPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VIVAPHARMA
Largest movements
- Cash +€56,314
up €56,314 (+123.0%), from €45,789 to €102,103
mainly Net result for the year (+€118,241) and Stocks and contracts (+€16,423)
- Stocks and contracts -€16,423
down €16,423 (-21.4%), from €76,915 to €60,492
- Intangible fixed assets -€7,000
down €7,000 (-19.3%), from €36,339 to €29,339
- Tangible fixed assets -€3,872
down €3,872 (-24.4%), from €15,891 to €12,019
of which Plant, machinery and equipment: -€2,828
- Profit (loss) carried forward +€118,241
up €118,241 (+1417.9%), from €8,339 to €126,580
- Other debts -€67,415
down €67,415 (-99.9%), from €67,465 to €50
- Debts after one year -€14,308
down €14,308 (-23.3%), from €61,276 to €46,968
- Tax, wage and social debts -€4,407
down €4,407 (-36.6%), from €12,040 to €7,633
of which Taxes: -€2,785
- Gross operating margin +€44,594
up €44,594 (+35.0%), from €127,324 to €171,918
- Taxes +€13,826
up €13,826 (+53.7%), from €25,748 to €39,574
- Depreciation -€3,396
down €3,396 (-23.8%), from €14,268 to €10,872
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €203,957 | €236,296 | +€32,338 | +15.9% |
| Fixed assets | 21/28 | €52,229 | €41,358 | -€10,872 | -20.8% |
| Intangible fixed assets | 21 | €36,339 | €29,339 | -€7,000 | -19.3% |
| Tangible fixed assets | 22/27 | €15,891 | €12,019 | -€3,872 | -24.4% |
| Plant, machinery and equipment | 23 | €14,847 | €12,019 | -€2,828 | -19.0% |
| Furniture and vehicles | 24 | €1,044 | - | -€1,044 | |
| Current assets | 29/58 | €151,728 | €194,938 | +€43,210 | +28.5% |
| Stocks and contracts in progress | 3 | €76,915 | €60,492 | -€16,423 | -21.4% |
| Stocks | 30/36 | €76,915 | €60,492 | -€16,423 | -21.4% |
| Amounts receivable within one year | 40/41 | €29,024 | €31,381 | +€2,357 | +8.1% |
| Trade receivables | 40 | €29,024 | €31,381 | +€2,357 | +8.1% |
| Cash at bank and in hand | 54/58 | €45,789 | €102,103 | +€56,314 | +123.0% |
| Deferred charges and accrued income | 490/1 | - | €963 | +€963 | |
| Total equity and liabilities | 10/49 | €203,957 | €236,296 | +€32,338 | +15.9% |
| Equity | 10/15 | €8,539 | €126,780 | +€118,241 | +1384.7% |
| Contributions | 10/11 | €200 | €200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,339 | €126,580 | +€118,241 | +1417.9% |
| Amounts payable | 17/49 | €195,418 | €109,516 | -€85,902 | -44.0% |
| Amounts payable after more than one year | 17 | €61,276 | €46,968 | -€14,308 | -23.3% |
| Financial debts | 170/4 | €61,276 | €46,968 | -€14,308 | -23.3% |
| Amounts payable within one year | 42/48 | €134,142 | €62,522 | -€71,620 | -53.4% |
| Current portion of amounts payable after more than one year | 42 | €15,792 | €14,308 | -€1,484 | -9.4% |
| Trade debts | 44 | €38,845 | €40,531 | +€1,686 | +4.3% |
| Suppliers | 440/4 | €38,845 | €40,531 | +€1,686 | +4.3% |
| Taxes, remuneration and social security | 45 | €12,040 | €7,633 | -€4,407 | -36.6% |
| Taxes | 450/3 | €10,418 | €7,633 | -€2,785 | -26.7% |
| Remuneration and social security | 454/9 | €1,622 | - | -€1,622 | |
| Other amounts payable | 47/48 | €67,465 | €50 | -€67,415 | -99.9% |
| Accrued charges and deferred income | 492/3 | - | €26 | +€26 | |
| Remuneration, social security and pensions | 62 | -€422 | - | +€422 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,268 | €10,872 | -€3,396 | -23.8% |
| Other operating charges | 640/8 | €94 | €62 | -€32 | -33.8% |
| Non-recurring operating charges | 66A | €310 | - | -€310 | |
| Gross operating margin | 9900 | €127,324 | €171,918 | +€44,594 | +35.0% |
| Operating profit (loss) | 9901 | €113,075 | €160,984 | +€47,909 | +42.4% |
| Financial charges | 65/66B | €3,480 | €3,169 | -€310 | -8.9% |
| Recurring financial charges | 65 | €3,480 | €3,169 | -€310 | -8.9% |
| Profit (loss) for the period before taxes | 9903 | €109,595 | €157,815 | +€48,220 | +44.0% |
| Income taxes | 67/77 | €25,748 | €39,574 | +€13,826 | +53.7% |
| Profit (loss) for the period | 9904 | €83,847 | €118,241 | +€34,394 | +41.0% |
| Profit (loss) for the period to be appropriated | 9905 | €83,847 | €118,241 | +€34,394 | +41.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.